T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
W.P. Carey
WPC
$16.4B
| $27M | ﹤0.01% |
335,492
-10,050
| -3% | -$769K |
|
|
TXNM
1202
TXNM Energy Inc
TXNM
$5.91B
| $27M | ﹤0.01% |
590,939
-201,572
| -25% | -$9.69M |
|
1203
Hagerty
HGTY
$1.31B
| $26.9M | ﹤0.01% |
+2,000,000
| New | +$31.2M |
|
1204
Wabtec
WAB
$50.7B
| $26.9M | ﹤0.01% |
292,384
-1,976
| -0.7% | -$181K |
|
1205
Amplitude
AMPL
$1.63B
| $26.9M | ﹤0.01% |
507,858
+152,839
| +43% | +$9.64M |
|
|
PDCE
1206
DELISTED
PDC Energy, Inc.
PDCE
| $26.8M | ﹤0.01% |
550,204
-210,465
| -28% | -$10.8M |
|
1207
FS Bancorp
FSBW
$326M
| $26.7M | ﹤0.01% |
793,298
-139
| -0% | -$4.76K |
|
|
DAWN
1208
DELISTED
Day One Biopharmaceuticals
DAWN
| $26.6M | ﹤0.01% |
1,580,978
+74,652
| +5% | +$1.53M |
|
1209
Revolution Medicines
RVMD
$43.2B
| $26.6M | ﹤0.01% |
1,055,771
+35,925
| +4% | +$1.01M |
|
1210
First Bancorp
FBNC
$2.75B
| $26.5M | ﹤0.01% |
579,976
+3,525
| +0.6% | +$165K |
|
1211
Iron Mountain
IRM
$38B
| $26.5M | ﹤0.01% |
505,864
-16,964
| -3% | -$802K |
|
1212
Principal Financial Group
PFG
$24.6B
| $26.4M | ﹤0.01% |
365,456
-23,571
| -6% | -$1.64M |
|
1213
Interparfums
IPAR
$3.66B
| $26.4M | ﹤0.01% |
246,576
+239,255
| +3,268% | +$21.5M |
|
1214
Masco
MAS
$14.7B
| $26.2M | ﹤0.01% |
372,845
-27,444
| -7% | -$1.78M |
|
|
IAS
1215
DELISTED
Integral Ad Science
IAS
| $26.1M | ﹤0.01% |
1,177,300
-25,984
| -2% | -$592K |
|
1216
UDR
UDR
$12.2B
| $26.1M | ﹤0.01% |
435,463
-3,079
| -0.7% | -$173K |
|
1217
Omnicom Group
OMC
$24.1B
| $26.1M | ﹤0.01% |
356,460
-16,957
| -5% | -$1.21M |
|
|
CCF
1218
DELISTED
Chase Corporation
CCF
| $26.1M | ﹤0.01% |
262,332
-19,491
| -7% | -$1.99M |
|
1219
Cincinnati Financial
CINF
$26.6B
| $26M | ﹤0.01% |
228,429
-10,821
| -5% | -$1.28M |
|
1220
Qorvo
QRVO
$8.55B
| $25.9M | ﹤0.01% |
165,678
-10,908
| -6% | -$1.73M |
|
1221
Royal Caribbean
RCL
$82.3B
| $25.9M | ﹤0.01% |
336,692
-4,082
| -1% | -$332K |
|
|
BCPC
1222
Balchem Corp
BCPC
$5.66B
| $25.8M | ﹤0.01% |
153,151
+138,974
| +980% | +$22.3M |
|
1223
Williams-Sonoma
WSM
$28.6B
| $25.8M | ﹤0.01% |
305,204
-3,234
| -1% | -$301K |
|
1224
Abercrombie & Fitch
ANF
$4.8B
| $25.7M | ﹤0.01% |
737,952
-172,195
| -19% | -$6.73M |
|
1225
Terex
TEX
$7.72B
| $25.6M | ﹤0.01% |
581,445
-653,755
| -53% | -$29.4M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.